Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
162.3 USD | -0.23% | -3.17% | +4.84% |
Apr. 30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
Apr. 29 | Health Care Up on Growth Optimism -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.84% | 288B | |
+32.90% | 704B | |
+28.59% | 577B | |
-3.66% | 348B | |
+18.24% | 327B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.16% | 147B | |
-5.87% | 145B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- AbbVie Says Potential Treatment for Giant Cell Arteritis Met Endpoints in Phase 3 Study